Iris Uniroma1 Prodmetadata only
How to best exploit immunotherapeutics in advanced gastric cancer: between biomarkers and novel cell-based approaches
immune checkpoint inhibitor, gastric cancer, epstein barr viru, tumor mutational burden, microsatellite instability, predictive biomarker, car t cell therapy, vaccines
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 250634
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.